GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lee's Pharmaceutical Holdings Ltd (HKSE:00950) » Definitions » PS Ratio

Lee's Pharmaceutical Holdings (HKSE:00950) PS Ratio : 0.61 (As of Jul. 16, 2025)


View and export this data going back to 2002. Start your Free Trial

What is Lee's Pharmaceutical Holdings PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Lee's Pharmaceutical Holdings's share price is HK$1.45. Lee's Pharmaceutical Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$2.38. Hence, Lee's Pharmaceutical Holdings's PS Ratio for today is 0.61.

The historical rank and industry rank for Lee's Pharmaceutical Holdings's PS Ratio or its related term are showing as below:

HKSE:00950' s PS Ratio Range Over the Past 10 Years
Min: 0.5   Med: 2.27   Max: 7.93
Current: 0.6

During the past 13 years, Lee's Pharmaceutical Holdings's highest PS Ratio was 7.93. The lowest was 0.50. And the median was 2.27.

HKSE:00950's PS Ratio is ranked better than
84.17% of 954 companies
in the Drug Manufacturers industry
Industry Median: 2.38 vs HKSE:00950: 0.60

Lee's Pharmaceutical Holdings's Revenue per Sharefor the six months ended in Dec. 2024 was HK$1.26. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$2.38.

During the past 12 months, the average Revenue per Share Growth Rate of Lee's Pharmaceutical Holdings was 33.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 3.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was 0.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was 3.30% per year.

During the past 13 years, Lee's Pharmaceutical Holdings's highest 3-Year average Revenue per Share Growth Rate was 46.80% per year. The lowest was -4.70% per year. And the median was 20.50% per year.

Back to Basics: PS Ratio


Lee's Pharmaceutical Holdings PS Ratio Historical Data

The historical data trend for Lee's Pharmaceutical Holdings's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lee's Pharmaceutical Holdings PS Ratio Chart

Lee's Pharmaceutical Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.29 1.55 0.78 0.86 0.60

Lee's Pharmaceutical Holdings Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 1.40 0.86 - 0.60

Competitive Comparison of Lee's Pharmaceutical Holdings's PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Lee's Pharmaceutical Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lee's Pharmaceutical Holdings's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lee's Pharmaceutical Holdings's PS Ratio distribution charts can be found below:

* The bar in red indicates where Lee's Pharmaceutical Holdings's PS Ratio falls into.


;
;

Lee's Pharmaceutical Holdings PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Lee's Pharmaceutical Holdings's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=1.45/2.377
=0.61

Lee's Pharmaceutical Holdings's Share Price of today is HK$1.45.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Lee's Pharmaceutical Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$2.38.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Lee's Pharmaceutical Holdings  (HKSE:00950) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Lee's Pharmaceutical Holdings PS Ratio Related Terms

Thank you for viewing the detailed overview of Lee's Pharmaceutical Holdings's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lee's Pharmaceutical Holdings Business Description

Traded in Other Exchanges
N/A
Address
Hong Kong Science Park, 1st Floor, Building 20E, Phase 3, Shatin, Hong Kong, HKG
Lee's Pharmaceutical Holdings Ltd is a research-driven and market-oriented biopharmaceutical company. Along with its subsidiaries, it develops, manufactures, sells, and markets pharmaceutical products. It focuses on cardiovascular, women's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. The company's reportable segments are; Proprietary and generic products which generates key revenue, and Licensed-in products. The Proprietary Products portfolio includes Livaracine, Yallaferon, Slounase, and Nadroparin Calcium Injection. Its Licensed-in Products include Centraxal Plus, Dicoflor, Ferplex, and Natulan among others. Geographically, the company generates a majority of its revenue from the People's Republic of China.
Executives
Leelalertsuphakun Wanee 2101 Beneficial owner
Lion River I N.v. 2201 Interest of corporation controlled by you
Li Zhenfu 2201 Interest of corporation controlled by you
Assicurazioni Generali Spa 2201 Interest of corporation controlled by you
Huang Zuie-chin 2201 Interest of corporation controlled by you
Lue Shuk Ping Vicky 2202 Interest of your spouse
Li Xiaoyi 2101 Beneficial owner
Lee Siu Fong 2101 Beneficial owner
Ubs Group Ag 2201 Interest of corporation controlled by you
Panacea Venture Healthcare Fund Ii, L.p. 2101 Beneficial owner
Panacea Innovation Limited 2201 Interest of corporation controlled by you
Guang Dong Min Ying Tou Zi Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Apta Finance Sa 2201 Interest of corporation controlled by you
Qualister Sa 2101 Beneficial owner
Paponi Claudia 2202 Interest of your spouse

Lee's Pharmaceutical Holdings Headlines

No Headlines